A patient who suffered a recurring thrombosis over the last 15 yr has been investigated. The only abnormality found in this patient was a significantly depressed level of plasminogen activity in plasma. In spite of the depressed plasminogen activity, the patient was found to have a normal level of plasminogen antigen concentration. It was calculated that the activity per milligram of plasminogen of the patient was approximately one-half the values of normal subjects. The same discrepancy between biological activity and antigen concentration was found in the other members of the kindred. A niece was found to have practically no plasminogen activity but possessed a normal concentration of plasminogen antigen. Both her parents were found to have approximately half the normal plasminogen activity and normal antigen levels. These studies suggested that the molecular abnormality was inherited as an autosomal characteristic, and the family members who had half the normal levels of activity with normal plasminogen antigen were heterozygotes whereas the one with practically no plasminogen activity was homozygote. Subsequent studies showed that the pattern of gel electrofocusing of purified plasminogen of the heterozygotes consisted of 10 normal bands and 10 additional abnormal bands, each of which had a slightly higher isoelectric point than each corresponding normal component. This indicates that plasminogen of the heterozygote is a mixture of normal and abnormal […] Find the latest version: A B S T R A C T A patient who suffered a recurring thrombosis over the last 15 yr has been investigated. The only abnormality found in this patient was a significantly depressed level of plasminogen activity in plasma. In spite of the depressed plasminogen activity, the patient was found to have a normal level of plasminogen antigen concentration. It was calculated that the activity per milligram of plasminogen of the patient was approximately one-half the values of normal subjects. The same discrepancy between biological activity and antigen concentration was found in the other members of the kindred. A niece was found to have practically no plasminogen activity but possessed a normal concentration of plasminogen antigen. Both her parents were found to have approximately half the normal plasminogen activity and normal antigen levels. These studies suggested that the molecular abnormality was inherited as an autosomal characteristic, and the family members who had half the normal levels of activity with normal plasminogen antigen were heterozygotes whereas the one with practically no plasminogen activity was homozygote. Subsequent studies showed that the pattern of gel electrofocusing of purified plasminogen of the heterozygotes consisted of 10 normal bands and 10 additional abnormal bands, each of which had a slightly higher isoelectric point than each corresponding normal component. This indicates that plasminogen of the heterozygote is a mixture of' normal and abnormal molecules in an approximately equal amount, which was substantiated by active site titration of purified plasminogen preparations obtained from the propositus and a normal individual. The gel electrofocusing Portions of this work were presented at the annual meeting of the Japanese Society of Hematology, Kanazawa, Japan.
A B S T R A C T A patient who suffered a recurring thrombosis over the last 15 yr has been investigated. The only abnormality found in this patient was a significantly depressed level of plasminogen activity in plasma. In spite of the depressed plasminogen activity, the patient was found to have a normal level of plasminogen antigen concentration. It was calculated that the activity per milligram of plasminogen of the patient was approximately one-half the values of normal subjects. The same discrepancy between biological activity and antigen concentration was found in the other members of the kindred. A niece was found to have practically no plasminogen activity but possessed a normal concentration of plasminogen antigen. Both her parents were found to have approximately half the normal plasminogen activity and normal antigen levels. These studies suggested that the molecular abnormality was inherited as an autosomal characteristic, and the family members who had half the normal levels of activity with normal plasminogen antigen were heterozygotes whereas the one with practically no plasminogen activity was homozygote. Subsequent studies showed that the pattern of gel electrofocusing of purified plasminogen of the heterozygotes consisted of 10 normal bands and 10 additional abnormal bands, each of which had a slightly higher isoelectric point than each corresponding normal component. This indicates that plasminogen of the heterozygote is a mixture of' normal and abnormal molecules in an approximately equal amount, which was substantiated by active site titration of purified plasminogen preparations obtained from the propositus and a normal individual. The gel electrofocusing
INTRODUCTION
Plasminogen is a zymogen in plasma that is converted to active protease plasmin by plasminogen activators released from various sources including vascular walls. This plasminogen-plasmin system is a major part of the fibrinolytic mechanism in vivo and is believed to play an important role in limiting the extent of fibrin deposition. The reduction of fibrinolytic activity, whatever the mechanism of the redtuction may be, may provoke a thrombotic tendency by allowing the growth and development of thrombi after an initiating thrombotic event. This prediction is supported by reports of animal studies (1, 2) , as well as by clinical reports (3) (4) (5) (6) , in which developmenit of thromboembolism follows suppression of fibrinolytic activity by the administration of antifibrinolytic agents or the increase of natural inhibitors of fibrinolysis. Inadequate release of plasminogen activator resulting in reduced fibrinolytic activity is also thought to be an accelerating factor for the development of venous thrombosis (7) . A thrombotic tendency cauisedl by an impaired fibrinolysis due to a plasminogeni (eficieincy, however, has not been documented. In the present study, a patient with recurring thrombosis was shown to have abnormally low plasminogen activity but normal levels of immunoreactive plasminogen. The abnormality of plasminogen was found to be inherited.
METHODS
Plasma. Blood was collected from antecubital veins into '/ho vol of 3.8% sodium citrate and was centrifuged at 2,000 g for 20 min to prepare plasma. Plastic syringes, centrifulge tubes, and storage containers were used. Plasma was stored at -80°C until use.
Normal subjects. 23 normal adults served as controls for the study of plasminogen.
Patients with liver cirrhosis. Plasminogen from 15 patients with liver cirrhosis of varying severity was studied. The diagnosis was based on the pathological appearance of the tissue specimens obtained by liver biopsy performed under laparoscopy as well as on laboratory examinations.
Purification of plasminogen. Plasminogen was prepared from human fresh plasma or plasma that had been stored at -80°C in 1 mM protease inhibitor, phenylmethyl sulfonylfluoride (Sigma Chemical Co., St. Louis, Mo.). Plasma was first subjected to affinity chromatography according to the method of Brockway and Castellino (8) . Plasminogen fractions I and II, which were eluted from lysine-coupled Sepharose were combined, and further purified by DEAESephadex chromatography (9) .
Assayfor plasminogen activity. Plasma plasminogen was assayed by the caseinolytic method (10) . Plasma (0.5 ml) was mixed and incubated with 0.5 ml of 1/6 N HCl for 15 min at room temperature to destroy plasmin inhibitor (11) and then neutralized with 0.5 ml of l/6 N NaOH and 1 ml of phosphate-buffered saline (0.1 M phosphate, 0.9% NaCl, pH 7.6). To plasma thus treated 0.5 ml of 2,000 U/ml streptokinase (Varidase, Lederle Laboratories, Pearl River, N. Y.) was added together with 2 ml of 5% casein (Hammarsten, AG Merck, Darmstadt, W. Germany). The mixture was incubated at 37°C. After 2 min 2 ml was withdrawn and mixed with 2 ml of 15% trichloroacetic acid. This served as the control. After 62 min incubation of the original mixture a further 2-ml sample was withdrawn and mixed with 2 ml of 15% trichloroacetic acid. The mixtures were allowed to stand for 30 min at room temperature. The precipitates formed were removed by repeated centrifugation, and the optical density of each solution was measured at 280 nm. The results were expressed in Remmert and Cohen casein units (12) . The casein unit used in the present study, however, should be regarded as an arbitrary unit, because it was not calibrated against a CTA (Committee on Thrombolytic Agents) unit or an international standard in which the assay is carried out with a-casein as a substrate (13, 14) . To insure the results, 500 U/ml urokinase was also used instead of streptokinase. Both methods using streptokinase or urokinase gave nearly identical results.
A euglobulin fraction of plasma was also used for the assay of plasminogen. Plasma (0.5 ml) was diluted with 9.5 ml of cold 0.016% acetic acid, and left in an ice-water bath for 30 min. The precipitate formed was collected by centrifugation, dissolved with 2.5 ml of phosphate-buffered saline, and subjected to the assay for plasminogen by the method described above for acid-treated plasma. This method gave values roughly 10% less than those obtained by activating acidtreated plasma. The results obtained by streptokinase activation of acid-treated plasma were used for plasminogen activity unless otherwise indicated.
Purified plasminogen was assayed also by an esterolytic method. Plasminogen was first activated in 25% glycerol solution with 2,000 U/ml streptokinase at 25°C for 5 min. Plasmin formed was assayed by the potentiometric method (15) using N-acetyl-glycyl-L-lysine methyl ester (Protein Research Foundation, Osaka, Japan) as a substrate. 1 U was defined as the activity catalyzing the hydrolysis of 1 ,umol of substrate/min.
Assay for plasminogen concentration. Plasminogen (antigen) concentration was measured by the single radial immunodiffusion technique of Mancini et al. (16) . 10 ,l of antigen solution (purified plasminogen or plasma) was placed in a hole (2.4-mm diameter) in the agarose layer (0.8% agarose in barbital buffer, pH 8.6, 0.05 M, containing 0.05% sodium azide, and 1.8-mm thickness) containing 0.5% of antiplasminogen antiserum on a glass plate, and was left in a moist chamber for 72 h. Diameters of'the resulting rings of immuneprecipitates were measured. Dilutions of known amounts of' purified plasminogen wvere made with 0.9% NaCl containing 3% bovine albumin and used for calibration. There was a linear relationship between the diameter2 of' the rings and amounts of antigen applied up to 50 mg/100 ml (Fig. 1) . Purified plasminogen used for calibration was prepared by the method of Brockway and Castellino (8) and was a single component when analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (17) . The antiplasminogen antiserum used was the one described previously (18) , and was monospecific when analyzed by immunoelectrophoresis as well as by double immunodiff'usion technique on agarose. Protein concentration of purified plasminogen used for calibration was determined by measuring the absorbance of the plasminogen solution (pH 7.4) at 280 nm and converting absorbance to protein concentration using El = 17.0 for purified plasminogen (19) .
Active site titration. Active sites of plasmin were titrated with p-nitrophenyl p '-guanidinobenzoate HCl (ICN Nutritional Biochemicals Div., International Chemical Nuclear Corp., Cleveland, Ohio) according to the method described by Chase and Shaw (20) .
Amino-terminal analysis. The amino-terminal group of plasminogen molecules was analyzed using dansyl chloride (21) . Dansylated amino acids were identified by thinlayer chromatography on polyamide sheets (21) . Closed circles, purified plasminogen. Open circles, normal standard plasma.
Hereditary Molecular Abnormality of Plasminogen
Gel electrophoresis. Sodium dodecyl sulfate (SDS)' polyacrylamide gel electrophoresis was performed with 5% polyacrylamide gels according to the method of Weber and Osborn (17) .
Analytical gel electrofocusing. Analytical thin-layer gel electrofocusing in polyacrylamide (5%) gel was performed with Ampholine (LKB Produkter AB, Bromma, Sweden) (6.7%), pH range 5-8.5, using LKB Multiphor apparatus (LKB Produkter AB, Bromma, Sweden) according to the methods described by Vesterberg (22) and those in the instruction manual supplied by the company. Electrophoresis was carried out at 400 V for 1 h and then at 900 V for an additional 2 h at 4°C.
Preparative isoelectric focusing. Separations by isoelectric focusing methods were carried out according to methods described by Vesterberg (23) , with the LKB model 8100 jacketed column (440-ml capacity). Fractions of 3.8 ml were collected by gravity flow at a regulated flow rate of 1.5 ml/min. The protein content and plasminogen antigen content of each fraction were determined from its absorbance at 280 nm and by the single radial immunodiffusion technique described above, respectively. Plasminogen activity was assayed by an esterolytic method. The pH of each fraction was measured at room temperature using a Radiometer TTTIa pH-meter (Radiometer Co., Copenhagen, Denmark).
Assay for concentration of proteinase inhibitors. Concentrations of proteinase inhibitors in plasma such as a2-macroglobulin, a1-antitrypsin, and a2-plasmin inhibitor (a2PI) were determined by single radial immunodiffusion technique (16) . Partigen plates (Behring-Werke AG, Marburg/ Lahn, West Germany) were used for a2-macroglobulin and a,-antitrypsin. a2PI was measured as described above for measurement of plasminogen antigen concentration using anti-a2PI antiserum (24) and purified a2PI (24) as a reference.
Antithrombin III assay. Antithrombin III activity of I Abbreviations used in this paper: a2PI, a2-plasmin inhibitor; pl, isoelectric point; SDS, sodium dodecyl sulfate.
-I---plasma was assayed by the method of Monkhouse (25) and expressed as a percent of normal pooled plasma. Antithrombin III (antigen) concentration was measured by the single radial immunodiffusion technique using Partigen plates (Behringwerke AG).
Routine coagulation and fibrinolysis tests. Prothrombin time was performed by the method of Quick (26) . Activated partial thromboplastin time was performed by the method described by Denson (27) . Fibrinogen content of plasma was assayed by the method of Ratnoff and Menzie (28) . Platelets were counted by a Coulter Counter (Coulter Electronics Inc., Hialeah, Fla.). Platelet aggregation studies were performed by the turbidimetric method of Born (29) using an Aggregometer (Bryston Co., Canada). Concentrations of fibrinogen/fibrin degradation products were estimated by hemagglutination inhibition test of Merskey et al. (30) . Euglobulin clot lysis time was performed by the method of von Kaulla and Schultz (31) .
Statistical analyses. Comparisons of the samples were performed using Cochran's modification of' Student's t analysis (32) , and other statistical analyses were done by the standard methods.
RESULTS
Case history. The propositus (subject 11-10 in Family history. Because of the striking thrombotic tendency of the patient, his family members were subjected to study except for one of his maternal uncles anid one of his nephews, neither of whom were available.
NoIne of these family members reported any episode suggestive of thrombosis. Two sisters had had two miscarriages each. There was no history of consanguinity.
Laboratory evaluations. The propositus was evaluated for evidence of coagulation/fibrinolysis abnormalities. The results are presented in Table I . The only abnormality found was a low activity of plasminogen. This low plasminogen activity was also found when assayed by urokinase activation of acid-treated plasma as well as urokinase or streptokinase activation of euglobulin fraction. The initiation of anticoagulant therapy did not affect the level of plasminogen activity and it remained constantly low. Other laboratory tests, including liver function tests, serum electrophoresis, C-reactive protein, antinuclear antibody, and other parameters of the presence of inflammatory processes or collagen disease, were all normal or negative.
Evaluation of plasminogen. The plasminogen abnormality found in the propositus was further investigated. Plasminogen caseinolytic activities and antigen concentrations in plasma samples obtained from the propositus on three different occasions over 3 mo during which there was no sign of' thrombosis were 0.69, 0.72, 0.67 U/ml and 14.6, 13.4, 13.5 mg/100 ml, respectively.
When 23 normal, healthy Japanese adults were studied, plasminogen caseinolytic activities and antigen concentrations were found to be 1.68 + 0.14 (mean+SE) U/ml and 15.7+1.3 (mean±SE) mg/10() ml, respectively. From these values, it was concluded that plasmiinogen activity in plasmua of the propositus was abnormally low although the conicentration of' plasminogen antigen was within the normal range. Caseinolytic activity per milligram plasminogen (antigen) in plasma of' the propositus To make sure that the low caseinolytic activity of plasminogen in plasma of the abnormal family members was not due to impaired liver function, the relationship between caseinolytic activity and antigen concentration was studied in patients with liver cirrhosis in whom production of plasminogen in liver is reported to be reduced, and the result was compared with that of the abnormal family members (Fig. 3) . In liver cirrhosis, caseinolytic activity is reduced in proportion to the decrease of antigen concentration, and the ratio of caseinolytic activity to antigen con- * Pedigree position refers to the pedigree in Fig. 2 . centration remains approximately the same as that of normal healthy controls (Fig. 3 ). This is represented in Fig. 3 by a good correlation (r = 0.91) observed between caseinolytic activity and antigen concentration in plasma of a group consisting of patients with liver cirrhosis and normal subjects. In the abnormal family members, the ratio of caseinolytic activity to antigen concentration was quite different from that of a group of the normal control and liver cirrhosis, and was approximately half that of normal control and liver cirrhosis. This is represented in Fig. 3 Molecular abnormality of plasminogen. Plasma samples of the propositus, his mother, and a normal healthy control were separately subjected to affinity chromatography on lysine-coupled Sepharose. Protein elution profiles are shown in Fig. 4 . The peak of absorbance of plasminogen fraction I (Glu-1-form) which was eluted first was generally lower than that of fraction II (Glu-2-form) in normal control, whereas in the case of the propositus and his mother the peak of absorbance of fraction I was higher than that of fraction II.
Plasminogen fractions I and II were separately concentrated by lyophilization. Each lyophilized material was dissolved with 2 ml of distilled water, dialyzed against Tris 0.05 M-NaCl 0.15 M, pH 7.4, and subsequently analyzed for activity and antigen concentra- Elution profiles of affinity chromatography of plasminogen on lysine-coupled Sepharose. 10 ml of fresh plasma of normal control or the propositus was applied to a column of lysine-coupled Sepharose (1.4 x 5.9 cm) equilibrated with Tris-saline (0.15 M NaCl, 0.05 M Tris-HCl, 1 mM EDTA, pH 7.4). The column was washed first with 50 ml of Tris-saline and then with 150 ml of Tris-saline containing 2 M NaCl at a flow rate at 8 ml/h. After washing, the adsorbed proteins were eluted with a linear gradient with the reservoir containing 100 ml of 25 mM 6-aminohexanoic acid in Tris-saline and the mixing chamber containing 100 ml of Tris-saline. The flow rate was maintained at 8 ml/h, and fractions of 3.6 ml each were collected. The procedures were carried out at 4°C. Fractions I and II, indicated by brackets, were separately concentrated and subjected to analyses. tion. The results are presented in Table III , which shows that both caseinolytic and esterolytic activities per milligram plasminogen in each fraction of the propositus were less than half (roughly 40%) of those of corresponding fractions of normal control. These fractions were combined and analyzed by SDS gel electrophoresis and immunoelectrophoresis. No difference of patterns of SDS gel electrophoresis and immunoelectrophoresis was observed between plasminogen of the propositus and that of the normal control, and the results of SDS gel electrophoresis are presented in Fig. 5 . Plasminogen of a normal control and that of the propositus were activated separately with urokinase, and each plasmin formed was analyzed by SDS gel electrophoresis (Fig. 5) . The patterns show the characteristic heavy and light chains of plasmin, and no significant difference was observed between the samples. The specific activities of the plasmin of normal control and the propositus were 16 and 7.3 casein U/mg protein, respectively.
Active sites of plasmin of normal control and the propositus were titrated with p-nitrophenyl p'-guanidinobenzoate HCI. Plasminogen preparations of a normal control and the propositus at three different concentrations ranging from 0.2 to 1.2 mg/ml were separately activated with 10,000 U/ml streptokinase at 25°C for 1 h in 0.05 M Veronal (Wako Pure Chemical Industries, Osaka, Japan) buffer containing 25% glycerol (pH 8.3). The plasmin formed was then titrated for active sites. Active site concentrations of normal control and the propositus were found to be 0.83 and 0.36 active sites on average per mole of protein, respectively.
The fractions obtained by another run of the chromatography were combined and further purified by DEAE-Sephadex chromatography. DEAE-Sephadex chromatography was necessary to remove contaminants often revealed by SDS gel electrophoresis in the preparations after the affinity chromatography. Remarkable differences of thin-layer gel electrofocusing pattern were constantly observed between plasminogen of the propositus or his mother and that of a normal control. As shown in Fig. 6A , the pattern of plasminogen of the normal control consisted of 10 clearly separated major bands, whereas the patterni of plasminogen of the propositus and his mother conitained an additional 10 bands, each of which was located to the basic side and closely parallel to each corresponding normal band, giving an appearance of splitting each normal band. When the plasminogen of the propositus or his mother was rtun very closely side by side with normal plasminogen, one of each pair of bands located to the acidic side fused with each corresponding normal band. This may indicate that the plasminogen is heterozygous and is a mixture of normal components and abnormal components with slightly higher isoelectric point (pl) values than normals. In contrast to these results obtained with heterozygous plasminogen, the pattern of electrofocusing of homozygous plasminogen (III-4) consisted of 10 instead of 20 bands of heterozygous plasminogen and the pattern itself was similar to that of normal control as shown in Fig. 6 B. The pattern of the mixture of homozygous and normal plasminogens in approximately equal amounts was similar to that of heterozygous plasminogen (Fig. 6 B) , indicating that all the components of homozygous plasminogen separated by electrofocusing represent the abnormal components of heterozygous plasminogen.
Fractionation of plasminogen by isoelectric focusing. Plasminogen of the propositus was fractionated by preparative isoelectric focusing methods. Plasmino--I.. l.: .. gen (50 mg) prepared by affinity chromatography on lysine-Sepharose and without DEAE chromatography was electrofocused in the 440-ml column in 4% Ampholine, pH range 5-7, at 900 V for 72 h at 4°C. The absorbance pH patterns are shown in Fig. 7 . Six protein peaks were obtained with pl ranging from pH 6 to 6.7. However, each protein peak was rather broad, and separation of abnormal components from normal components was not visible. Consequently, the fractions in the range of pH 5.9-6.8 (fraction no. were combined and directly rerun by isoelectric focusing in the 440-ml column at 900 V for 144 experienced no thrombotic event. The only physical abnormality she now has is a tendency to form induration in subcutaneous tissues after minor trauma. Whether or not this has anything to do with deficiency of plasminogen is not known at the present time.
The biochemical defect in family Y is apparently transmitted by an autosomal gene and has an incomplete recessive character. The defect found was the production of altered plasminogen molecules. In the affected members in the kindred, biological activity per unit of quantity of plasminogen determined by immunochemical method was found to be nearly half of a normal control. Furthermore, the analyses by electrofocusing of plasminogen purified f'rom plasma of heterozygotes or homozygotes suggested that the plasminogen in the heterozygotes is a mixture of' normal molecules and altered nonf'unctioning molecules in about equal amounts. Active-site titration of plasmin of a normal control and the propositus suggested that plasminogen of the propositus consisted of abnormal and normal molecules in a ratio of 57 and 43%, respectively. These results are in accordance with the generally accepted rule of autosomal genes that the heterozygote produces one-half normal protein and one-half mutant protein.
Plasminogen analyzed was a mixture of Glu-1-and Glu-2-forms. Normal control plasminogen consisted of 10 major components with different pl values (Fig.  6) . Summaria et al. (38) also found a total of 10 isoelectric forms with different pl values in Glu-1-plus Glu-2-forms by acrylamide gel electrophoresis in the presence of' E-aminocaproic acid. Multiple molecular isoelectric f'orms of plasminogen were explained by the difference of their sialic acid content (39) . Abnormal plasminogen molecules also consisted of' 10 major components, each of which had a slightly higher pl value than each corresponding normal component. When heterozygous plasminogen was fractionated by preparative isoelectric focusing methods with pH range 5-7, six isoelectric forms with pl values 6, 6.15, 6.3, 6.4, 6.6, and 6.7 were obtained (Fig. 7) . These isoelectric forms are essentially the same as those obtained by Wallen and Wiman (9) , and the four acidic forms among these six forms were identified as Gluplasminogen (9, 40) . These fractions of Glu-plasminogen were electrofocused again using the narrower pH range 5.9-6.8. By this second isoelectric focusing, each of three isoelectric forms with pl values 6, 6.15, and 6.3 in Fig. 7 was separated into two components (Fig. 8) . The difference of pl values of the two components of each pair was rather constant, being 0.03-0.04. The acidic component of each pair was associated with plasminogen activity as well as plasminogen antigen, whereas the basic component of each pair was associated with no or less plasminogen activity but possessed plasminogen antigen (Fig. 8) . The latter components may represent nonfunctioning, altered components of heterozygous plasminogen, whose pl values are higher than each corresponding normal component by 0.03-0.04. Plasminogen of the homozygote seems to be composed of abnormal components only (Fig. 6 B) , but detailed studies on homozygote plasminogen have not yet been possible due to a lack of material because the homozygote is a 6-yr-old girl. The question as to whether the altered molecular f'orms resulted from an amino acid substitution or from the variance of carbohydrate content is the interesting subject to be solved in the future studies.
Apart from the structural alteration, it is interesting to note that an amount of' Glu-2-form was less thain that of' Glu-1-form in plasma of the aff'ected individuals (Fig. 4 ) in contrast to normal control. This is reflected in patterns of' electrofocusing as the comparatively low density of basic bands as seen particularly in the middle pattern of Fig. 6 A.
Subject 11-2 was found to be heterozygote in spite of the relatively high plasminogen activity (1.29 U/ml). This is ascribed to abnormally increased amounts of' plasminogen antigen in plasma (21.8 mg/100 ml vs. the normal control values 15.7±1.3 mg/100 ml). A compensatory mechanism which accelerates the production of plasminogen might be operating in this particular subject.
Subject , who is heterozygote and the f;ather of subject 111-4 (homozygote), came from a family that has lived for generations in the same region (Utsunomiya) as family Y. This might suggest the possibility of the prevalence of the gene responsible for abnormal plasminogen at least in this particular geographical region. An alternative is that this cooupling of heterozygotes was indeed the unusual chance of the rare gene. The development of' a rapid screening method for the detection of' the abnormal plasminogen would make it possible to elucidate the fre(luency and distribution of this gene.
